Background: PHD-histone interactions are essential in epigenetic signaling. Results: Calixarenes can disrupt PHD-H3K4me complexes in vitro and in vivo. Conclusion: The inhibitory activity of calixarenes depends on the binding affinities of PHD fingers for H3K4me and the methylation state of histone. Significance: This approach provides new tools for probing histone binding activities of methyllysine readers.
translocation partner NUP98, triggers hematopoietic malignancies (11) . Binding of the PHD fingers to H3K4me3 is essential for tumor-suppressive, or, in some instances, oncogenic mechanisms of the inhibitor of growth 1-5 (ING1-5) proteins (reviewed in Ref. 12 ). Loss of the third PHD (PHD3) finger of the methyltransferase MLL1 in the MLL-ENL translocation causes constitutive transactivation of the fused protein, which promotes leukemogenesis (13) . Mutations in the PHD finger of RAG2 have been found in patients with severe combined immunodeficiency syndrome and in Omenn syndrome, in which V(D)J recombination and the formation of T and B cell receptors are impaired (14) . Owing to their prominent role in epigenetic regulation, the PHD finger-containing proteins could be valuable diagnostic markers or pharmacological targets in preventing or treating these diseases.
Recent breakthroughs in biological and medical applications of small molecule antagonists for acetyllysine-binding bromodomain, methyllysine-binding MBT and chromodomain, and arginine-recognizing WD40 demonstrate the vast potential of targeting the histone readers (15) (16) (17) (18) (19) (20) . A number of epigenetic inhibitors are in clinical trials as anticancer and antiinflammatory agents (15, 21, 22) . Many more show beneficial effects in animal and cellular models and are used successfully in testing the biological activities of reader-, writer-and erasercontaining proteins. To date, various small molecule inhibitors and peptidomimetics have been designed to block the interaction of a histone reader by competing with a histone substrate for the same narrow, deep, and therefore druggable binding site. However, the histone H3K4me3 tail is bound in a wide and shallow binding site of the PHD finger. This binding site is not easily amenable to the design of conventional small molecule inhibitors, and only a few groups have reported progress in this regard (23, 24) .
Alternatively, PTM-reader complexes could be disrupted using chemicals that target PTMs rather than readers. Supramolecular caging compounds, including synthetic receptors, chelating macrocycles, and calixarenes, have been shown to coordinate unmodified and posttranslationally modified amino acids and, therefore, can be applied for studying epigenetic mechanisms (25-31, 45, 46) . We have demonstrated previously that calixarenes inhibit binding of the second PHD finger of CHD4 to histone H3 trimethylated at Lys-9, although this binding does not involve the formation of a methyllysine-recognizing aromatic cage (32, 33) . Here we characterize the mechanisms by which calixarenes interact with the canonical PHD-H3K4me3 complexes and examine the effect of the aromatic cage architecture on these interactions. Our results reveal that calixarenes display selectivity in disrupting the association of PHD fingers with the methylated histone H3K4 tail. We show that the calixarene activity relies on differences in binding affinities of the PHD fingers for H3K4me and the methylation state of the histone substrate and that the caging compound can be modified further to enhance its inhibitory capability toward individual PHD fingers. This approach provides new tools for probing biological functions of the methyllysine readers.
Experimental Procedures
Synthesis of Calix [4] arene Derivatives-Calixarene (1) was purchased from TCI America. Calixarenes (2) (3) (4) (5) (6) (7) (8) were synthesized as described in Refs. 26, 32 and the supplemental Experimental Procedures.
Fluorescence Displacement Assay-The FDA was performed as described in the supplemental Experimental Procedures.
Protein Purification-The constructs containing the ING2 PHD (212-264), MLL5 PHD (117-181), MLL1 PHD3 (1565-1627), and JARID1A PHD3 (1608 -1659) were expressed in Escherichia coli Rosetta2 BL21(DE3) pLysS cells in Luria broth or [ 15 N]H 4 Cl-supplemented minimal media. Protein production was induced with 0.5 mM isopropyl 1-thio-␤-D-galactopyranoside at 18°C overnight. Bacterial cells were harvested by centrifugation and lysed by sonication. The 15 N-labeled GST fusion proteins were purified by GST affinity chromatography on glutathione-Sepharose 4B beads (GE Healthcare). The GST tag was cleaved with Prescission or Thrombin (GE Healthcare) proteases. The cleaved proteins were eluted and concentrated in a buffer containing 20 mM Tris-HCl (pH 6.9), 150 mM NaCl, and 5 mM dithiothreitol.
NMR Spectroscopy-NMR experiments were performed on 500-and 600-MHz Varian INOVA spectrometers at 298 K. 1 H, 15 N heteronuclear single-quantum coherence (HSQC) spectra were recorded for each 15 N-labeled PHD finger (0.1 mM) in the absence and presence of saturating concentrations of H3K4me2 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) or H3K4me3 (1-12) peptides (synthesized by the UCD Biophysics Core Facility). Subsequently, increasing amounts of calixarenes were added in a stepwise manner. K d values were calculated by a nonlinear least squares analysis in Kaleidagraph using the following equation:
is the concentration of the peptide, [P] is concentration of the protein, ⌬␦ is the observed chemical shift change, and ⌬␦ max is the normalized chemical shift change at saturation. The normalized chemical shift change was calculated using the equation [(⌬␦H) 2 ϩ (⌬␦N / 5) 2 ] 0.5 , where ␦ is chemical shift in parts per million (ppm).
Pulldown Assays-GST fusion MLL5 PHD and ING2 PHD proteins (50 M) were incubated with 5 M C-terminal biotinylated peptides (AnaSpec) corresponding to the H3K4me3 (residues 1-21) and H3K4me2 (residues 1-21) histone tails in the presence or absence of 100 M of calixarenes in 50 l of binding buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 0.2% Triton X-100 at room temperature for 2 h. Streptavidinagarose resin (Thermo Scientific) was added to the reaction mixture and incubated for an additional 2 h. The beads were collected via centrifugation and washed with binding buffer. The bound protein was detected by Coomassie staining of an SDS-PAGE gel.
Fluorescence Polarization Assays-Peptides for fluorescence polarization (histone H3, residues 1-20) were synthesized as described previously (34) with the addition of 5-carboxyfluorescein at the C terminus. Binding assays were performed as described previously (35) with the following modifications. Reactions were performed in 25 l in black flat bottom 384-well plates (Costar). Protein was titrated with 20 nM peptide in buffer containing 25 mM HEPES (pH 7.5), 100 mM NaCl, and 0.05% Nonidet P-40. Following a 10-min equilibration period at 25°C, the plates were read on a PHERAstar microplate reader (BMG Labtech) using a 480-nm excitation filter and 520/ 530-nm emission filters. For displacement assays, the indicated concentrations of (1) were incubated with MLL5 PHD (10 M) or ING2 PHD (5 M) and 20 nM tracer peptide in the buffer described above. Anisotropy units were normalized to the signal in the absence of (1) (100% bound). IC 50 values were determined by variable slope non-linear regression analysis and a least squares fit using GraphPad Prism v5.
Cell Line and Culture-C2C12 cells were grown in DMEM supplemented with 10% FBS and penicillin/streptomycin (100 units/ml). To create the MLL5-expressing cell line, C2C12 cells were transfected with a Tol2 transposon containing full-length murine MLL5 with an N-terminal FLAG tag under the control of a Tet-responsive element and a puromycin resistance marker and the rtTA2S-M2 Tet activator under the control of a PGK promoter (the sequence file can be found in the in supplemental ExperimentalProcedures) along with the Tol2 transposase. Integrants were selected and maintained on 2 g/ml puromycin.
Proximity Ligation Assay-10,000 C2C12:FLAG-MLL5 cells were seeded into each well of an 8-well Lab-Tek chamber slide with or without 1 g/ml doxycycline and grown at 37°C, 5% CO 2 . After 16 h, (1) or vehicle control was added to the appropriate wells, and cells were incubated for a further 8 h. The final concentration of (1) was 100 M diluted from a 25 mM stock in 50% DMSO. Cells were fixed with 4% formaldehyde, permeabilized with 0.5% saponin and 1% Triton X-100 in PBS, and processed with the DuoLink proximity ligation assay kit (Sigma-Aldrich, catalog no. DUO92101) according to the instructions of the manufacturer. FLAG-MLL5 was labeled with a mouse monoclonal anti-FLAG antibody (Sigma-Aldrich, catalog no. F1804), and histone H3K4me3 was labeled with a rabbit polyclonal antibody (Active Motif, catalog no. 39159) diluted 1:2000 and 1:500, respectively, in the diluent provided with the kit. Cells were imaged using a Delta Vision Elite fluorescence microscope with a ϫ60 objective, and images were analyzed by manually counting fluorescent spots in three dimensions using the Imaris software suite. 88 -104 cells were quantitated for each condition.
Protein Extracts and Western Blot Analysis-Transfected cells were washed with PBS once, resuspended in Nonidet P-40/sucrose buffer (0.32 M sucrose, 3 mM CaCl 2 , 2 mM MgCl 2 , 0.1 mM EDTA, and 0.5% Nonidet P-40) and incubated on ice for 5 min. Nuclei were pelleted at 1500 ϫ g and washed once with sucrose buffer without Nonidet P-40. For Western blots, the nuclei were resuspended in radioimmune precipitation assay buffer, sonicated (avoiding overheating), and incubated on ice for 10 min. The samples were spun at 14,000 ϫ g for 15 min at 4°C, and the supernatants were recovered. 50 g of extract was resolved in 4 -20% acrylamide gel and transferred to PVDF by standard methods. Membranes were blotted with mouse anti-FLAG (1:5000, Sigma-Aldrich, catalog no. F1804) and rabbit anti-PARP-1 (1:2000, Santa Cruz Biotechnology, catalog no. sc-1750).
Immunofluorescence-10,000 C2C12:FLAG-MLL5 cells were seeded into each well of an 8-well Lab-Tek chamber slide with or without 1 g/ml doxycycline and grown at 37°C, 5% CO 2 for 24 h. For calixarene-treated cells, vehicle or 100 M (1) diluted from a 25 mM stock in 50% DMSO was added for the final 8 h. Cells were fixed with 4% formaldehyde and permeabilized with 0.5% saponin, 1% Triton X-100 in PBS. FLAG-MLL5 was labeled with a mouse monoclonal anti-FLAG antibody (Sigma-Aldrich, catalog no. F1804) diluted 1:2000 and with an anti-mouse Cy3 secondary antibody (Jackson ImmunoResearch Laboratories, catalog no. 715-165-150) diluted 1:250. H3K4me3 was labeled with rabbit polyclonal antibody (Active Motif, catalog no. 39159) diluted 1:500 and with an anti-rabbit Cy3 secondary antibody (Jackson ImmunoResearch Laboratories, catalog no. 711-165-152) diluted 1:250. Slides were SEPTEMBER 18, 2015 • VOLUME 290 • NUMBER 38 mounted with the media included with the Duolink PLA kit and imaged using a Delta Vision Elite fluorescence microscope with identical exposure settings for each condition.
Supramolecular Hosts for Histone H3K4me3

Results and Discussion
Design of Calixarene Derivatives-PHD fingers recognize histone H3K4me3 by enclosing trimethyllysine in a cage-like binding pocket that consists of at least one and up to four aromatic residues. Generally, the side chains of these aromatic residues protrude almost perpendicularly to the protein surface and to each other and are involved in cationinteractions with the trimethylammonium group of Lys-4 ( Fig. 1, a and b) . In search for approaches to inhibit binding of the PHD fingers to H3K4me3, we designed a set of water-soluble calix [4] arenes (Fig. 1c ). The four linked phenol repeats of calix [4] arenes form a rigid bucket-shape scaffold, enabling these compounds to trap methylated lysine in the internal cavity. Because the internal volume and the diameter of the upper rim of calix [4] arenes match the internal volume and distances between the aromatic groups in the aromatic cage of the PHD finger, we rationalized that these calixarenes can mimic the natural K4me3-binding site of the protein (Fig. 1b ). The set of calixarenes included analogs of p-sulfonatocalixarene (1) carrying amide-or sulfonamide-linked substituents at one or two positions of its upper rim (2-8) ( Fig. 1c) (26, 32) . The bulkiness and electrostatic properties of the substituents varied to determine how change in polarity, size, and charge affects the ability of calixarenes to disrupt the PHD-H3K4me3 complexes.
Selectivities of Calixarenes for Methylated Histone H3-To examine the effect of substituents on the methyllysine-binding activity of (1), we characterized the association of calixarenes (1-7) with histone H3K4me3 peptide (residues 1-12 of H3) using an FDA ( Fig. 2a ). In this assay, the histone peptide was titrated into a calixarene sample containing a Lucigenin dye. Displacement of the dye by H3K4me3 was monitored through the change in fluorescence intensity at 485 nm. The equilibrium dissociation constant (K d ) for the complex of calixarene (1) with H3K4me3 peptide was found to be 15 nM ( Fig. 2b) . Substitution of one of the sulfonate groups in (1) with a bulkier, negatively charged or neutral moiety had no effect on this interaction. However, p-bromo-phenyl substituents in (3) and (6) significantly reduced histone binding, which was further weak-FIGURE 2. Calixarenes display a selectivity for methylated histone peptides. a, representative FDA binding curves for the indicated peptides and calixarenes. b, dissociation constants measured by FDA. Selectivity for H3K4me3 determined by the ratio of H3K4me3 versus H3K9me3. Data are mean Ϯ S.D. c, modeling of the complexes of (1) with H3K4me3 and H3K9me3 peptides. The electrostatic surface potential of the peptides was generated in PyMOL. ened in the case of (7), a calixarene carrying two p-carboxyphenylsulfonamide groups.
The amino terminus of native histone H3 can also be trimethylated at Lys-9. Interestingly, the H3K4me3 and H3K9me3 PTMs are associated with opposite biological outcomes. Whereas the former is found at promoters of actively transcribed genes, the latter is a mark of transcriptionally inactive pericentric heterochromatin. To determine whether calixarenes select for specific sequences adjacent to trimethyllysine, we tested the binding of (1-7) to histone H3K9me3 peptide (residues 1-12 of H3) by FDA ( Fig. 2 ). We found that the added substituents in general decrease binding of (1) to H3K9me3, and bromophenyl-substituted calixarenes (3) and (6) associate even weaker. A comparison of the binding affinities of calixarenes toward H3K4me3 and H3K9me3 reveals that some calixarenes display a preference for H3K4me3, whereas others select for H3K9me3. Particularly (1), (4), and (5) showed ϳ8-, ϳ12-, and ϳ10-fold selectivity toward H3K4me3 over H3K9me3, respectively, whereas (3) and (7) slightly preferred H3K9me3. These data suggest energetically favorable contacts of (1), (4), and (5) with the peptide residues surrounding K4me3. Modeling of the H3K4me3-(1) complex positioned the negatively charged sulfonate groups of (1) in close proximity to the positively charged side chains of the Arg-2 and Arg-8 of the peptide. Such additional electrostatic interactions are not possible in the H3K9me3-(1) complex, where the negatively charged upper rim of (1) packs against the polar and hydrophobic Ser-10, Thr-11, and Ala-7 residues of the peptide. Together, FDA experiments demonstrate that (1), (4), and (5) preferentially bind H3K4me3 and can be used to modulate the histone-binding activities of H3K4me3-specific readers, including PHD fingers.
Inhibition of the ING2 PHD-H3K4me3 interaction-The ability of calixarenes to disrupt PHD finger binding to histone H3K4me3 was examined by NMR spectroscopy (Fig. 3 ). We collected 1 H, 15 N HSQC spectra of the uniformly 15 N-labeled PHD finger of ING2 while H3K4me3 peptide was added gradually to the NMR sample. As anticipated, the histone peptide induced large chemical shift perturbations (CSPs) in the protein, confirming direct interaction with H3K4me3 (Fig. 3b , first panel, red gradient colors). Progressive shifting and broadening of cross-peaks revealed an intermediate exchange regime on the NMR time scale, which was consistent with the binding affinity of the ING2 PHD finger measured for H3K4me3 (K d , 1.5 M) (3). Subsequent titration of (1) caused the amide resonances of the ING2 PHD finger to shift back to their positions in the ligand-free form of the protein (blue gradient colors, Fig.  3b ), indicating dissociation of the PHD-H3K4me3 complex and formation of a supramolecular H3K4me3-(1) complex. Contrary to (1), we found that the carboxyphenylsulfonamide ana-log (4) does not disrupt the PHD-H3K4me3 complex despite the fact that both calixarenes interact with the H3K4me3 peptide almost equally well (Fig. 3b, second panel) . The less bulkier phenyl analog (8) showed a weak inhibition at a PHD: H3K4me3:(8) ratio of 1:5:5 (Fig. 3b, third panel) . These results suggest that steric hindrance reduces the inhibitory activity of calixarenes carrying large substituents toward the ING2 PHD finger complex.
The majority of CSPs in the ING2 PHD finger triggered by H3K4me3 were reversed complementarily by (1), however, cross-peaks of Lys-251 and Trp-254 of the protein shifted to a different position ( Fig. 3c and supplemental Fig. S1 ). To test whether these residues are involved in a nonspecific interaction with (1), we titrated (1) into the ING2 PHD finger in the absence of H3K4me3 (Fig. 3, d-f ). Substantial CSPs observed for Lys-251 and Trp-254 confirmed that these residues are likely involved in an off-target interaction with (1). The calculated K d value of ϳ730 M for this nonspecific interaction was ϳ10 4fold higher than the K d value for the specific coordination of H3K4me3 and was in line with affinities measured previously for weak nonspecific associations between calixarenes and proteins (25) .
Inhibition of the ING2 PHD-H3K4me3 interaction by (1) was corroborated by pulldown assays. We incubated GST-ING2 PHD with biotinylated histone H3K4me3 peptide (resi- dues 1-20) and with streptavidin-Sepharose beads in the absence and presence of calixarenes. After collecting the bead fraction through centrifugation, the histone-bound PHD finger was detected by Western blot analysis (Fig. 4a ). In the absence of (1), the ING2 PHD finger bound to H3K4me3, however, treatment with (1) abrogated this interaction. In support of the NMR titration experiments, (8) only slightly diminished the association of the PHD finger with H3K4me3. Therefore, among all calixarenes tested, (1) appears to be the most effective inhibitor of the ING2 PHD-H3K4me3 interaction. Fluorescence polarization displacement assays revealed a dose-dependent inhibition of the ING2 PHD-H3K4me3 complex by (1), with an IC 50 of 108 M (Fig. 4b) .
Calixarenes Do Not Affect the ING2 PHD-H3K4me2 Complex-Both trimethylated species and dimethylated species, H3K4me3 and H3K4me2, have been found in overlapping genomic regions near the gene transcription start sites, however, these PTMs regulate chromatin in a different way. The ING2 PHD finger binds to H3K4me2 with an appreciable for an epigenetic reader affinity (K d , 15 M) even though it is ϳ10-fold weaker as compared to the affinity of this protein for H3K4me3 (K d , 1.5 M) (3). We analyzed the ability of calixarenes to block binding of the ING2 PHD finger to H3K4me2 using 1 H, 15 N HSQC titration experiments (Fig. 4c) . In contrast to robust inhibition of the stronger interaction of the ING2 PHD finger with H3K4me3, we found that (1) does not inhibit the weaker interaction of the ING2 PHD finger with H3K4me2 at the same protein:peptide:calixarene ratio of 1:5:5. Calixarene (4) was also unable to disrupt the PHD-H3K4me2 complex. In agreement, the GST-ING2 PHD finger recognized immobilized biotinylated H3K4me2 peptide either in the presence or absence of (1), confirming that (1) does not eliminate binding of the PHD finger to H3K4me2 (Fig. 4a) . This, at first glance counterintuitive, finding can be explained in terms of the host-guest capabilities of calixarenes. Calixarene (1) has been shown to select for a trimethylated lysine residue over an unmodified lysine residue by ϳ70-fold (26), therefore, this high selectivity most likely accounts for its inability to disrupt the ING2 PHD-H3K4me2 complex.
Together, the NMR and pulldown data reveal that (1) inhibits binding of the ING2 PHD finger to H3K4me3 without affecting its binding to another physiologically relevant ligand, H3K4me2. The strong selectivity of (1) offers a unique (3, 11, 36, 37) . The aromatic cage residues of ING2, JARID1A, MLL1, and MLL5 are labeled and colored pink, yellow, blue, and green, respectively. c, an overlay of the K4me3-binding pockets of ING2, JARID1A, MLL1, and MLL5. d, summary of the K d values and aromatic cage topologies of the PHD fingers.
approach to separate the two functions of the PHD finger, which would be impossible to achieve using a conventional small molecule inhibitor of the protein.
Effects of Affinity and the Aromatic Cage Topology-The topology of the aromatic cage and histone binding affinities vary significantly among PHD fingers. In attempt to develop calixarene-based derivatives selective for a particular group of readers, we compared the PHD fingers of JARID1A, ING2, MLL1, and MLL5. The aromatic cages of MLL5, JARID1A, ING2, and MLL1 contain one, two, two, and three aromatic residues, respectively ( Fig. 5 ). Furthermore, the four PHD fingers have dissimilar methyllysine pocket geometries. The trimethylated lysine in the MLL5-H3K4me3 complex occupies a channel whose walls are made of Trp-141 and Asp-128, whereas Met-132 resides at the bottom (Fig. 5b) (36) . JARID1A is characterized by a shallow V-shaped groove consisting of two tryptophan residues, Trp-1625 and Trp-1635 (11) . By contrast, the two aromatic residues of ING2, Tyr- To determine whether (1) can impede the functions of other PHDs, we characterized the histone-binding activity of the JARID1A PHD3 finger. Addition of (1) to the 15 N-labeled JARID1A PHD3 finger, prebound to the unlabeled H3K4me3 peptide, led to substantial CSPs and nearly restored the spectrum of the ligand-free PHD finger at a protein:H3K4me3:(1) ratio of 1:5:10 (Fig. 6) . Much like the reverse pattern of CSPs observed earlier for ING2, the reverse pattern of CSPs for JARID1A indicated dissociation of the JARID1A PHD3-FIGURE 6. Calixarenes exhibit selectivity for the PHD fingers of JARID1A and MLL1. a, the crystal structure of the JARID1A PHD3 finger in complex with H3K4me3 peptide (PDB code 3GL6). The aromatic cage residues are colored yellow. b, superimposed 1 H, 15 N HSQC spectra of JARID1A PHD3, collected as first H3K4me3 peptide and then (1), (4), or (7) were titrated in. The spectra are color-coded according to the protein:peptide:calixarene molar ratio. c, overlays of 1 H, 15 N HSQC spectra of the H3K4me2-bound JARID1A PHD3 recorded during titration with (1). d, superimposed 1 H, 15 N HSQC spectra of MLL1 PHD3 collected as first H3K4me3 peptide and then (1), (4), and (7) were added gradually. e, the crystal structure of the MLL1 PHD3 finger in complex with H3K4me3 peptide (PDB code 3GL6). The aromatic cage residues are colored blue. f, the normalized chemical shift changes observed in the MLL1 PHD finger upon binding to H3K3me3 (red) and inhibition by (1) or (4) (blue) as a function of residue.
H3K4me3 complex. Although the JARID1A PHD3 finger has a more shallow aromatic cage, it binds to H3K4me3 twice as strong as ING2 PHD binds to H3K4me3 (3, 11) . Accordingly, at least twice more of (1) was required to inhibit the association of the JARID1A PHD3 finger with H3K4me3. As expected, neither (4) nor (7) were able to perturb the JARID1A PHD3-H3K4me3 complex. Together, the NMR titration experiments suggest that the PHD-H3K4me3 complex dissociation constants, rather than the aromatic cage geometry, drive inhibition by calixarenes.
Unlike the ING2 PHD finger that binds to H3K4me2 ϳ10fold more weakly than it binds to H3K4me3, the JARID1A PHD3 finger recognizes both methylated states equally well (K d values of 0.8 and 0.9 M for H3K4me2 and H3K4me3, respectively) (3, 11) . Titration of (1) into the JARID1A PHD3-H3K4me2 complex resulted in no CSPs, indicating that (1) is incapable of eliminating binding of the JARID1A PHD3 finger to H3K4me2 (Fig. 6c ).
Calixarenes Disrupt Weak Complexes of MLL1 and MLL5-
Whereas ING2 and JARID1A PHDs represent typical PHD modules, with binding affinities toward H3K4me3 being in the range of 1-10 M, the PHD fingers of MLL1 and MLL5 bind H3K4me3 much weaker (K d values of ϳ 20 M) and associate with H3K4me2 in the 100 -200 M range (3, 11, 36 -38) . Despite the fact that trimethylated lysine in the MLL1 PHD3-H3K4me3 complex is completely buried in the aromatic cage, all tested calixarenes, including (1), (4), and (7) , were able to inhibit this interaction on the basis of reverse CSPs observed in the HSQC titration experiments (Fig. 6d ). Furthermore, (1) and (4) abolished the interaction equally well (Fig. 6f ), implying that a particular calixarene host could be chosen to eliminate the histone binding activity of a particular PHD finger. For instance, (4) disrupts the complex of the MLL1 PHD finger, whereas it does not disrupt the complexes of ING2 or JARID1A PHD fingers at the same calixarene concentration. FIGURE 7 . Calixarenes block the histone-binding activity of the MLL5 PHD finger in vitro and in vivo. a, crystal structure of the MLL5 PHD finger in complex with H3K4me3 peptide (PDB code 2LV9). The aromatic cage residues are colored green. b, superimposed 1 H, 15 N HSQC spectra of MLL5 PHD, collected as first H3K4me3 peptide and then (1), (4), or (7) were titrated in. The spectra are color-coded according to the protein:peptide:calixarene molar ratio. c, quantitation of the interaction of MLL5 PHD with H3 (black) or H3K4me3 (blue) peptides by fluorescence polarization (left) or fluorescence polarization displacement (right) by (1) . d, overlays of 1 H, 15 N HSQC spectra of the H3K4me2-bound MLL5 PHD recorded during titration with (1) or (7) . e, binding of the GST-fusion MLL5 PHD finger to the indicated biotinylated histone peptides in the absence or presence of the indicated calixarenes.
We next examined whether calixarenes can impede binding of the MLL5 PHD finger that contains a single aromatic residue in the binding cage using NMR and pulldown assays (Fig. 7) . We found that (1), (4), (7) , and (8) impair binding of the MLL5 PHD finger to H3K4me3, although (7) does so weakly (Fig. 7b ). Inhibition by (1) was dose-dependent and had an IC 50 of 37 M as measured by fluorescence polarization (Fig. 7c ). Moreover, (1) and (7) were capable of disrupting a weak (K d , 104 M) complex of the MLL5 PHD finger with H3K4me2 (Fig. 7, d and e) . These findings reinforce our conclusion that the topology of the aromatic cage appears to have no effect on the inhibition but binding affinity does play a significant role. These results also suggest that calixarenes (4), (7) , and (8) can be used to block the H3K4me-binding activity of the PHD fingers that weakly inter- act with this PTM (K d , Ͼ20 M) while not affecting the strong PHD-H3K4me complexes (K d , ϳ1 M).
Displacement of MLL5 by (1) in Vivo-Recruitment of MLL5 to chromatin has been shown to rely on binding of its PHD finger to H3K4me3 (36) . To determine whether calixarene inhibitors can disrupt the interaction of the PHD finger with H3K4me3 in vivo, we tested the chromatin localization of MLL5 using a Duolink PLA (Fig. 8) . We have previously optimized this assay to detect specifically and only directly interacting MLL5-H3K4me3 foci (36) . We generated a C2C12 cell line with an inducible full-length murine MLL5 harboring an N-terminal FLAG tag. C2C12:FLAG-MLL5 cells were treated with Ϯ100 M (1) and subjected to the PLA with primary antibodies against the FLAG tag and H3K4me3. FLAG-MLL5-H3K4me3interacting foci were detected by microscopy as fluorescent spots. In agreement with a previous report (36) , in the absence of inhibitors, a large number of fluorescent spots were observed in each nucleus, indicating that MLL5 localizes at the genomic regions enriched in H3K4me3 (Fig. 8a, center panel) . However, treatment of the cells with (1) substantially decreased the number of interacting foci, suggesting that MLL5 is disengaged from chromatin when calixarene is present (Fig. 8a, right panel) . Quantitative analysis of the experiments confirmed that treatment with (1) considerably reduced both the mean number of spots per cell and the fraction of cells with multiple spots (Fig. 8,  b and c) . These results are consistent with in vitro inhibition data and demonstrate that (1) can be used to eliminate the MLL5 PHD-H3K4me3 interaction in intact cells.
Concluding Remarks-Impaired histone-binding function of PHD fingers causes mislocalization and nuclear-to-cytosolic redistribution of the host proteins and chromatin-associating complexes, leading to genomic instability and deregulation of various signaling pathways (39) . Developing novel approaches to manipulate the activities of these proteins and complexes can be pivotal for understanding alterations in chromatin structure and gene expression patterns. A well documented link between aberrant activities of PHD finger-containing proteins and various human diseases points to vast therapeutic potential. Therefore, designing inhibitors of the PHD-histone interactions is also essential for advancing cutting edge, epigenetically driven therapeutic strategies (21) .
In this study, we show that supramolecular caging compounds impair the association of the PHD fingers with methylated H3K4 tails. The inhibitory activity of calixarenes depends on differences in binding affinities and the methylation state of the histone ligand and can be augmented toward certain PHD finger-histone complexes by further amending the caging compound. We demonstrate that calixarenes can target trimethyllysine and disrupt PHD-H3K4me3 complexes in vitro and in vivo. A unique architecture of the H3K4me3-PHD interface, the geometric complementarity of calix [4] arenes to the trimethyllysine-binding aromatic cage, and their cell permeability substantially widen the experimental applicability of the supramolecular hosts (40) . We expect these compounds to be used as novel tools in a wide array of biochemical assays, histone peptide microarrays, and high-throughput screens that aim to identify novel methyllysine readers and characterize histone binding mechanisms of known epigenetic readers. We note that fur-ther studies are necessary to examine whether calixarenes can disrupt complexes of other readers of the H3K4me3 PTM, including CHD1 double chromodomains, tandem Tudor domains of JMJD2A and SGF29, and a CW zinc finger of ZCWPW1 (41) (42) (43) (44) .
